Global Oxycodone Drug Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Oxycodone Drug market size was valued at US$ 2206 million in 2023. With growing demand in downstream market, the Oxycodone Drug is forecast to a readjusted size of US$ 3483.1 million by 2030 with a CAGR of 6.7% during review period.
The research report highlights the growth potential of the global Oxycodone Drug market. Oxycodone Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oxycodone Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oxycodone Drug market.
Oxycodoneis an opioid medication. It comes in tablet shape or liquid formation. It is used for the treatment of moderate to severe pain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Oxycodone Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oxycodone Drug market. It may include historical data, market segmentation by Type (e.g., Pain Management, Anesthesia), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oxycodone Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oxycodone Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oxycodone Drug industry. This include advancements in Oxycodone Drug technology, Oxycodone Drug new entrants, Oxycodone Drug new investment, and other innovations that are shaping the future of Oxycodone Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oxycodone Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Oxycodone Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oxycodone Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oxycodone Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oxycodone Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oxycodone Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oxycodone Drug market.
Market Segmentation:
Oxycodone Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Oxycodone Drug market?
What factors are driving Oxycodone Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oxycodone Drug market opportunities vary by end market size?
How does Oxycodone Drug break out type, application?
According to our LPI (LP Information) latest study, the global Oxycodone Drug market size was valued at US$ 2206 million in 2023. With growing demand in downstream market, the Oxycodone Drug is forecast to a readjusted size of US$ 3483.1 million by 2030 with a CAGR of 6.7% during review period.
The research report highlights the growth potential of the global Oxycodone Drug market. Oxycodone Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oxycodone Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oxycodone Drug market.
Oxycodoneis an opioid medication. It comes in tablet shape or liquid formation. It is used for the treatment of moderate to severe pain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Oxycodone Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oxycodone Drug market. It may include historical data, market segmentation by Type (e.g., Pain Management, Anesthesia), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oxycodone Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oxycodone Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oxycodone Drug industry. This include advancements in Oxycodone Drug technology, Oxycodone Drug new entrants, Oxycodone Drug new investment, and other innovations that are shaping the future of Oxycodone Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oxycodone Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Oxycodone Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oxycodone Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oxycodone Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oxycodone Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oxycodone Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oxycodone Drug market.
Market Segmentation:
Oxycodone Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Pain Management
- Anesthesia
- Others
- Hospitals & Clinics
- Ambulatory Surgical Centers (ASCs)
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Purdue Pharma L.P
- Janssen Pharmaceuticals(Johnson & Johnson)
- Hikma Pharmaceuticals USA
- Pfizer
- Sanofi-Aventis S.A.
- Sun Pharmaceutical Industries Ltd.
- Oxynorm
- OxyContin
- Endone
- Proladone
- Targin
What is the 10-year outlook for the global Oxycodone Drug market?
What factors are driving Oxycodone Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oxycodone Drug market opportunities vary by end market size?
How does Oxycodone Drug break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oxycodone Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Oxycodone Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Oxycodone Drug by Country/Region, 2019, 2023 & 2030
2.2 Oxycodone Drug Segment by Type
2.2.1 Pain Management
2.2.2 Anesthesia
2.2.3 Others
2.3 Oxycodone Drug Sales by Type
2.3.1 Global Oxycodone Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Oxycodone Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Oxycodone Drug Sale Price by Type (2019-2024)
2.4 Oxycodone Drug Segment by Application
2.4.1 Hospitals & Clinics
2.4.2 Ambulatory Surgical Centers (ASCs)
2.5 Oxycodone Drug Sales by Application
2.5.1 Global Oxycodone Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Oxycodone Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Oxycodone Drug Sale Price by Application (2019-2024)
3 GLOBAL OXYCODONE DRUG BY COMPANY
3.1 Global Oxycodone Drug Breakdown Data by Company
3.1.1 Global Oxycodone Drug Annual Sales by Company (2019-2024)
3.1.2 Global Oxycodone Drug Sales Market Share by Company (2019-2024)
3.2 Global Oxycodone Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Oxycodone Drug Revenue by Company (2019-2024)
3.2.2 Global Oxycodone Drug Revenue Market Share by Company (2019-2024)
3.3 Global Oxycodone Drug Sale Price by Company
3.4 Key Manufacturers Oxycodone Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oxycodone Drug Product Location Distribution
3.4.2 Players Oxycodone Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OXYCODONE DRUG BY GEOGRAPHIC REGION
4.1 World Historic Oxycodone Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Oxycodone Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Oxycodone Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oxycodone Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Oxycodone Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Oxycodone Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oxycodone Drug Sales Growth
4.4 APAC Oxycodone Drug Sales Growth
4.5 Europe Oxycodone Drug Sales Growth
4.6 Middle East & Africa Oxycodone Drug Sales Growth
5 AMERICAS
5.1 Americas Oxycodone Drug Sales by Country
5.1.1 Americas Oxycodone Drug Sales by Country (2019-2024)
5.1.2 Americas Oxycodone Drug Revenue by Country (2019-2024)
5.2 Americas Oxycodone Drug Sales by Type
5.3 Americas Oxycodone Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oxycodone Drug Sales by Region
6.1.1 APAC Oxycodone Drug Sales by Region (2019-2024)
6.1.2 APAC Oxycodone Drug Revenue by Region (2019-2024)
6.2 APAC Oxycodone Drug Sales by Type
6.3 APAC Oxycodone Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oxycodone Drug by Country
7.1.1 Europe Oxycodone Drug Sales by Country (2019-2024)
7.1.2 Europe Oxycodone Drug Revenue by Country (2019-2024)
7.2 Europe Oxycodone Drug Sales by Type
7.3 Europe Oxycodone Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oxycodone Drug by Country
8.1.1 Middle East & Africa Oxycodone Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Oxycodone Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Oxycodone Drug Sales by Type
8.3 Middle East & Africa Oxycodone Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oxycodone Drug
10.3 Manufacturing Process Analysis of Oxycodone Drug
10.4 Industry Chain Structure of Oxycodone Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oxycodone Drug Distributors
11.3 Oxycodone Drug Customer
12 WORLD FORECAST REVIEW FOR OXYCODONE DRUG BY GEOGRAPHIC REGION
12.1 Global Oxycodone Drug Market Size Forecast by Region
12.1.1 Global Oxycodone Drug Forecast by Region (2025-2030)
12.1.2 Global Oxycodone Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oxycodone Drug Forecast by Type
12.7 Global Oxycodone Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Purdue Pharma L.P
13.1.1 Purdue Pharma L.P Company Information
13.1.2 Purdue Pharma L.P Oxycodone Drug Product Portfolios and Specifications
13.1.3 Purdue Pharma L.P Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Purdue Pharma L.P Main Business Overview
13.1.5 Purdue Pharma L.P Latest Developments
13.2 Janssen Pharmaceuticals(Johnson & Johnson)
13.2.1 Janssen Pharmaceuticals(Johnson & Johnson) Company Information
13.2.2 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolios and Specifications
13.2.3 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Janssen Pharmaceuticals(Johnson & Johnson) Main Business Overview
13.2.5 Janssen Pharmaceuticals(Johnson & Johnson) Latest Developments
13.3 Hikma Pharmaceuticals USA
13.3.1 Hikma Pharmaceuticals USA Company Information
13.3.2 Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolios and Specifications
13.3.3 Hikma Pharmaceuticals USA Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Hikma Pharmaceuticals USA Main Business Overview
13.3.5 Hikma Pharmaceuticals USA Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Oxycodone Drug Product Portfolios and Specifications
13.4.3 Pfizer Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Sanofi-Aventis S.A.
13.5.1 Sanofi-Aventis S.A. Company Information
13.5.2 Sanofi-Aventis S.A. Oxycodone Drug Product Portfolios and Specifications
13.5.3 Sanofi-Aventis S.A. Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sanofi-Aventis S.A. Main Business Overview
13.5.5 Sanofi-Aventis S.A. Latest Developments
13.6 Sun Pharmaceutical Industries Ltd.
13.6.1 Sun Pharmaceutical Industries Ltd. Company Information
13.6.2 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolios and Specifications
13.6.3 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sun Pharmaceutical Industries Ltd. Main Business Overview
13.6.5 Sun Pharmaceutical Industries Ltd. Latest Developments
13.7 Oxynorm
13.7.1 Oxynorm Company Information
13.7.2 Oxynorm Oxycodone Drug Product Portfolios and Specifications
13.7.3 Oxynorm Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Oxynorm Main Business Overview
13.7.5 Oxynorm Latest Developments
13.8 OxyContin
13.8.1 OxyContin Company Information
13.8.2 OxyContin Oxycodone Drug Product Portfolios and Specifications
13.8.3 OxyContin Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 OxyContin Main Business Overview
13.8.5 OxyContin Latest Developments
13.9 Endone
13.9.1 Endone Company Information
13.9.2 Endone Oxycodone Drug Product Portfolios and Specifications
13.9.3 Endone Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Endone Main Business Overview
13.9.5 Endone Latest Developments
13.10 Proladone
13.10.1 Proladone Company Information
13.10.2 Proladone Oxycodone Drug Product Portfolios and Specifications
13.10.3 Proladone Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Proladone Main Business Overview
13.10.5 Proladone Latest Developments
13.11 Targin
13.11.1 Targin Company Information
13.11.2 Targin Oxycodone Drug Product Portfolios and Specifications
13.11.3 Targin Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Targin Main Business Overview
13.11.5 Targin Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oxycodone Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Oxycodone Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Oxycodone Drug by Country/Region, 2019, 2023 & 2030
2.2 Oxycodone Drug Segment by Type
2.2.1 Pain Management
2.2.2 Anesthesia
2.2.3 Others
2.3 Oxycodone Drug Sales by Type
2.3.1 Global Oxycodone Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Oxycodone Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Oxycodone Drug Sale Price by Type (2019-2024)
2.4 Oxycodone Drug Segment by Application
2.4.1 Hospitals & Clinics
2.4.2 Ambulatory Surgical Centers (ASCs)
2.5 Oxycodone Drug Sales by Application
2.5.1 Global Oxycodone Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Oxycodone Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Oxycodone Drug Sale Price by Application (2019-2024)
3 GLOBAL OXYCODONE DRUG BY COMPANY
3.1 Global Oxycodone Drug Breakdown Data by Company
3.1.1 Global Oxycodone Drug Annual Sales by Company (2019-2024)
3.1.2 Global Oxycodone Drug Sales Market Share by Company (2019-2024)
3.2 Global Oxycodone Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Oxycodone Drug Revenue by Company (2019-2024)
3.2.2 Global Oxycodone Drug Revenue Market Share by Company (2019-2024)
3.3 Global Oxycodone Drug Sale Price by Company
3.4 Key Manufacturers Oxycodone Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oxycodone Drug Product Location Distribution
3.4.2 Players Oxycodone Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OXYCODONE DRUG BY GEOGRAPHIC REGION
4.1 World Historic Oxycodone Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Oxycodone Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Oxycodone Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oxycodone Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Oxycodone Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Oxycodone Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oxycodone Drug Sales Growth
4.4 APAC Oxycodone Drug Sales Growth
4.5 Europe Oxycodone Drug Sales Growth
4.6 Middle East & Africa Oxycodone Drug Sales Growth
5 AMERICAS
5.1 Americas Oxycodone Drug Sales by Country
5.1.1 Americas Oxycodone Drug Sales by Country (2019-2024)
5.1.2 Americas Oxycodone Drug Revenue by Country (2019-2024)
5.2 Americas Oxycodone Drug Sales by Type
5.3 Americas Oxycodone Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oxycodone Drug Sales by Region
6.1.1 APAC Oxycodone Drug Sales by Region (2019-2024)
6.1.2 APAC Oxycodone Drug Revenue by Region (2019-2024)
6.2 APAC Oxycodone Drug Sales by Type
6.3 APAC Oxycodone Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oxycodone Drug by Country
7.1.1 Europe Oxycodone Drug Sales by Country (2019-2024)
7.1.2 Europe Oxycodone Drug Revenue by Country (2019-2024)
7.2 Europe Oxycodone Drug Sales by Type
7.3 Europe Oxycodone Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oxycodone Drug by Country
8.1.1 Middle East & Africa Oxycodone Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Oxycodone Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Oxycodone Drug Sales by Type
8.3 Middle East & Africa Oxycodone Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oxycodone Drug
10.3 Manufacturing Process Analysis of Oxycodone Drug
10.4 Industry Chain Structure of Oxycodone Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oxycodone Drug Distributors
11.3 Oxycodone Drug Customer
12 WORLD FORECAST REVIEW FOR OXYCODONE DRUG BY GEOGRAPHIC REGION
12.1 Global Oxycodone Drug Market Size Forecast by Region
12.1.1 Global Oxycodone Drug Forecast by Region (2025-2030)
12.1.2 Global Oxycodone Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oxycodone Drug Forecast by Type
12.7 Global Oxycodone Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Purdue Pharma L.P
13.1.1 Purdue Pharma L.P Company Information
13.1.2 Purdue Pharma L.P Oxycodone Drug Product Portfolios and Specifications
13.1.3 Purdue Pharma L.P Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Purdue Pharma L.P Main Business Overview
13.1.5 Purdue Pharma L.P Latest Developments
13.2 Janssen Pharmaceuticals(Johnson & Johnson)
13.2.1 Janssen Pharmaceuticals(Johnson & Johnson) Company Information
13.2.2 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolios and Specifications
13.2.3 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Janssen Pharmaceuticals(Johnson & Johnson) Main Business Overview
13.2.5 Janssen Pharmaceuticals(Johnson & Johnson) Latest Developments
13.3 Hikma Pharmaceuticals USA
13.3.1 Hikma Pharmaceuticals USA Company Information
13.3.2 Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolios and Specifications
13.3.3 Hikma Pharmaceuticals USA Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Hikma Pharmaceuticals USA Main Business Overview
13.3.5 Hikma Pharmaceuticals USA Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Oxycodone Drug Product Portfolios and Specifications
13.4.3 Pfizer Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Sanofi-Aventis S.A.
13.5.1 Sanofi-Aventis S.A. Company Information
13.5.2 Sanofi-Aventis S.A. Oxycodone Drug Product Portfolios and Specifications
13.5.3 Sanofi-Aventis S.A. Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sanofi-Aventis S.A. Main Business Overview
13.5.5 Sanofi-Aventis S.A. Latest Developments
13.6 Sun Pharmaceutical Industries Ltd.
13.6.1 Sun Pharmaceutical Industries Ltd. Company Information
13.6.2 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolios and Specifications
13.6.3 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sun Pharmaceutical Industries Ltd. Main Business Overview
13.6.5 Sun Pharmaceutical Industries Ltd. Latest Developments
13.7 Oxynorm
13.7.1 Oxynorm Company Information
13.7.2 Oxynorm Oxycodone Drug Product Portfolios and Specifications
13.7.3 Oxynorm Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Oxynorm Main Business Overview
13.7.5 Oxynorm Latest Developments
13.8 OxyContin
13.8.1 OxyContin Company Information
13.8.2 OxyContin Oxycodone Drug Product Portfolios and Specifications
13.8.3 OxyContin Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 OxyContin Main Business Overview
13.8.5 OxyContin Latest Developments
13.9 Endone
13.9.1 Endone Company Information
13.9.2 Endone Oxycodone Drug Product Portfolios and Specifications
13.9.3 Endone Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Endone Main Business Overview
13.9.5 Endone Latest Developments
13.10 Proladone
13.10.1 Proladone Company Information
13.10.2 Proladone Oxycodone Drug Product Portfolios and Specifications
13.10.3 Proladone Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Proladone Main Business Overview
13.10.5 Proladone Latest Developments
13.11 Targin
13.11.1 Targin Company Information
13.11.2 Targin Oxycodone Drug Product Portfolios and Specifications
13.11.3 Targin Oxycodone Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Targin Main Business Overview
13.11.5 Targin Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 2. Oxycodone Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Pain Management
Table 4. Major Players of Anesthesia
Table 5. Major Players of Others
Table 6. Global Oxycodone Drug Sales by Type (2019-2024) & (K Units)
Table 7. Global Oxycodone Drug Sales Market Share by Type (2019-2024)
Table 8. Global Oxycodone Drug Revenue by Type (2019-2024) & ($ million)
Table 9. Global Oxycodone Drug Revenue Market Share by Type (2019-2024)
Table 10. Global Oxycodone Drug Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Oxycodone Drug Sales by Application (2019-2024) & (K Units)
Table 12. Global Oxycodone Drug Sales Market Share by Application (2019-2024)
Table 13. Global Oxycodone Drug Revenue by Application (2019-2024)
Table 14. Global Oxycodone Drug Revenue Market Share by Application (2019-2024)
Table 15. Global Oxycodone Drug Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Oxycodone Drug Sales by Company (2019-2024) & (K Units)
Table 17. Global Oxycodone Drug Sales Market Share by Company (2019-2024)
Table 18. Global Oxycodone Drug Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Oxycodone Drug Revenue Market Share by Company (2019-2024)
Table 20. Global Oxycodone Drug Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Oxycodone Drug Producing Area Distribution and Sales Area
Table 22. Players Oxycodone Drug Products Offered
Table 23. Oxycodone Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Oxycodone Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Oxycodone Drug Sales Market Share Geographic Region (2019-2024)
Table 28. Global Oxycodone Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Oxycodone Drug Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Oxycodone Drug Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Oxycodone Drug Sales Market Share by Country/Region (2019-2024)
Table 32. Global Oxycodone Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Oxycodone Drug Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Oxycodone Drug Sales by Country (2019-2024) & (K Units)
Table 35. Americas Oxycodone Drug Sales Market Share by Country (2019-2024)
Table 36. Americas Oxycodone Drug Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Oxycodone Drug Revenue Market Share by Country (2019-2024)
Table 38. Americas Oxycodone Drug Sales by Type (2019-2024) & (K Units)
Table 39. Americas Oxycodone Drug Sales by Application (2019-2024) & (K Units)
Table 40. APAC Oxycodone Drug Sales by Region (2019-2024) & (K Units)
Table 41. APAC Oxycodone Drug Sales Market Share by Region (2019-2024)
Table 42. APAC Oxycodone Drug Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Oxycodone Drug Revenue Market Share by Region (2019-2024)
Table 44. APAC Oxycodone Drug Sales by Type (2019-2024) & (K Units)
Table 45. APAC Oxycodone Drug Sales by Application (2019-2024) & (K Units)
Table 46. Europe Oxycodone Drug Sales by Country (2019-2024) & (K Units)
Table 47. Europe Oxycodone Drug Sales Market Share by Country (2019-2024)
Table 48. Europe Oxycodone Drug Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Oxycodone Drug Revenue Market Share by Country (2019-2024)
Table 50. Europe Oxycodone Drug Sales by Type (2019-2024) & (K Units)
Table 51. Europe Oxycodone Drug Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Oxycodone Drug Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Oxycodone Drug Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Oxycodone Drug Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Oxycodone Drug Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Oxycodone Drug Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Oxycodone Drug Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Oxycodone Drug
Table 59. Key Market Challenges & Risks of Oxycodone Drug
Table 60. Key Industry Trends of Oxycodone Drug
Table 61. Oxycodone Drug Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Oxycodone Drug Distributors List
Table 64. Oxycodone Drug Customer List
Table 65. Global Oxycodone Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Oxycodone Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Oxycodone Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Oxycodone Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Oxycodone Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Oxycodone Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Oxycodone Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Oxycodone Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Oxycodone Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Oxycodone Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Oxycodone Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Oxycodone Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Oxycodone Drug Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Oxycodone Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Purdue Pharma L.P Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Purdue Pharma L.P Oxycodone Drug Product Portfolios and Specifications
Table 81. Purdue Pharma L.P Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Purdue Pharma L.P Main Business
Table 83. Purdue Pharma L.P Latest Developments
Table 84. Janssen Pharmaceuticals(Johnson & Johnson) Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolios and Specifications
Table 86. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Janssen Pharmaceuticals(Johnson & Johnson) Main Business
Table 88. Janssen Pharmaceuticals(Johnson & Johnson) Latest Developments
Table 89. Hikma Pharmaceuticals USA Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolios and Specifications
Table 91. Hikma Pharmaceuticals USA Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Hikma Pharmaceuticals USA Main Business
Table 93. Hikma Pharmaceuticals USA Latest Developments
Table 94. Pfizer Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Oxycodone Drug Product Portfolios and Specifications
Table 96. Pfizer Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Sanofi-Aventis S.A. Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Sanofi-Aventis S.A. Oxycodone Drug Product Portfolios and Specifications
Table 101. Sanofi-Aventis S.A. Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Sanofi-Aventis S.A. Main Business
Table 103. Sanofi-Aventis S.A. Latest Developments
Table 104. Sun Pharmaceutical Industries Ltd. Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolios and Specifications
Table 106. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Sun Pharmaceutical Industries Ltd. Main Business
Table 108. Sun Pharmaceutical Industries Ltd. Latest Developments
Table 109. Oxynorm Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Oxynorm Oxycodone Drug Product Portfolios and Specifications
Table 111. Oxynorm Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Oxynorm Main Business
Table 113. Oxynorm Latest Developments
Table 114. OxyContin Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. OxyContin Oxycodone Drug Product Portfolios and Specifications
Table 116. OxyContin Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. OxyContin Main Business
Table 118. OxyContin Latest Developments
Table 119. Endone Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Endone Oxycodone Drug Product Portfolios and Specifications
Table 121. Endone Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Endone Main Business
Table 123. Endone Latest Developments
Table 124. Proladone Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Proladone Oxycodone Drug Product Portfolios and Specifications
Table 126. Proladone Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Proladone Main Business
Table 128. Proladone Latest Developments
Table 129. Targin Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 130. Targin Oxycodone Drug Product Portfolios and Specifications
Table 131. Targin Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. Targin Main Business
Table 133. Targin Latest Developments
Table 2. Oxycodone Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Pain Management
Table 4. Major Players of Anesthesia
Table 5. Major Players of Others
Table 6. Global Oxycodone Drug Sales by Type (2019-2024) & (K Units)
Table 7. Global Oxycodone Drug Sales Market Share by Type (2019-2024)
Table 8. Global Oxycodone Drug Revenue by Type (2019-2024) & ($ million)
Table 9. Global Oxycodone Drug Revenue Market Share by Type (2019-2024)
Table 10. Global Oxycodone Drug Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Oxycodone Drug Sales by Application (2019-2024) & (K Units)
Table 12. Global Oxycodone Drug Sales Market Share by Application (2019-2024)
Table 13. Global Oxycodone Drug Revenue by Application (2019-2024)
Table 14. Global Oxycodone Drug Revenue Market Share by Application (2019-2024)
Table 15. Global Oxycodone Drug Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Oxycodone Drug Sales by Company (2019-2024) & (K Units)
Table 17. Global Oxycodone Drug Sales Market Share by Company (2019-2024)
Table 18. Global Oxycodone Drug Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Oxycodone Drug Revenue Market Share by Company (2019-2024)
Table 20. Global Oxycodone Drug Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Oxycodone Drug Producing Area Distribution and Sales Area
Table 22. Players Oxycodone Drug Products Offered
Table 23. Oxycodone Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Oxycodone Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Oxycodone Drug Sales Market Share Geographic Region (2019-2024)
Table 28. Global Oxycodone Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Oxycodone Drug Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Oxycodone Drug Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Oxycodone Drug Sales Market Share by Country/Region (2019-2024)
Table 32. Global Oxycodone Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Oxycodone Drug Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Oxycodone Drug Sales by Country (2019-2024) & (K Units)
Table 35. Americas Oxycodone Drug Sales Market Share by Country (2019-2024)
Table 36. Americas Oxycodone Drug Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Oxycodone Drug Revenue Market Share by Country (2019-2024)
Table 38. Americas Oxycodone Drug Sales by Type (2019-2024) & (K Units)
Table 39. Americas Oxycodone Drug Sales by Application (2019-2024) & (K Units)
Table 40. APAC Oxycodone Drug Sales by Region (2019-2024) & (K Units)
Table 41. APAC Oxycodone Drug Sales Market Share by Region (2019-2024)
Table 42. APAC Oxycodone Drug Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Oxycodone Drug Revenue Market Share by Region (2019-2024)
Table 44. APAC Oxycodone Drug Sales by Type (2019-2024) & (K Units)
Table 45. APAC Oxycodone Drug Sales by Application (2019-2024) & (K Units)
Table 46. Europe Oxycodone Drug Sales by Country (2019-2024) & (K Units)
Table 47. Europe Oxycodone Drug Sales Market Share by Country (2019-2024)
Table 48. Europe Oxycodone Drug Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Oxycodone Drug Revenue Market Share by Country (2019-2024)
Table 50. Europe Oxycodone Drug Sales by Type (2019-2024) & (K Units)
Table 51. Europe Oxycodone Drug Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Oxycodone Drug Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Oxycodone Drug Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Oxycodone Drug Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Oxycodone Drug Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Oxycodone Drug Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Oxycodone Drug Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Oxycodone Drug
Table 59. Key Market Challenges & Risks of Oxycodone Drug
Table 60. Key Industry Trends of Oxycodone Drug
Table 61. Oxycodone Drug Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Oxycodone Drug Distributors List
Table 64. Oxycodone Drug Customer List
Table 65. Global Oxycodone Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Oxycodone Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Oxycodone Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Oxycodone Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Oxycodone Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Oxycodone Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Oxycodone Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Oxycodone Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Oxycodone Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Oxycodone Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Oxycodone Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Oxycodone Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Oxycodone Drug Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Oxycodone Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Purdue Pharma L.P Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Purdue Pharma L.P Oxycodone Drug Product Portfolios and Specifications
Table 81. Purdue Pharma L.P Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Purdue Pharma L.P Main Business
Table 83. Purdue Pharma L.P Latest Developments
Table 84. Janssen Pharmaceuticals(Johnson & Johnson) Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolios and Specifications
Table 86. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Janssen Pharmaceuticals(Johnson & Johnson) Main Business
Table 88. Janssen Pharmaceuticals(Johnson & Johnson) Latest Developments
Table 89. Hikma Pharmaceuticals USA Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolios and Specifications
Table 91. Hikma Pharmaceuticals USA Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Hikma Pharmaceuticals USA Main Business
Table 93. Hikma Pharmaceuticals USA Latest Developments
Table 94. Pfizer Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Oxycodone Drug Product Portfolios and Specifications
Table 96. Pfizer Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Sanofi-Aventis S.A. Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Sanofi-Aventis S.A. Oxycodone Drug Product Portfolios and Specifications
Table 101. Sanofi-Aventis S.A. Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Sanofi-Aventis S.A. Main Business
Table 103. Sanofi-Aventis S.A. Latest Developments
Table 104. Sun Pharmaceutical Industries Ltd. Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolios and Specifications
Table 106. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Sun Pharmaceutical Industries Ltd. Main Business
Table 108. Sun Pharmaceutical Industries Ltd. Latest Developments
Table 109. Oxynorm Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Oxynorm Oxycodone Drug Product Portfolios and Specifications
Table 111. Oxynorm Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Oxynorm Main Business
Table 113. Oxynorm Latest Developments
Table 114. OxyContin Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. OxyContin Oxycodone Drug Product Portfolios and Specifications
Table 116. OxyContin Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. OxyContin Main Business
Table 118. OxyContin Latest Developments
Table 119. Endone Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Endone Oxycodone Drug Product Portfolios and Specifications
Table 121. Endone Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Endone Main Business
Table 123. Endone Latest Developments
Table 124. Proladone Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Proladone Oxycodone Drug Product Portfolios and Specifications
Table 126. Proladone Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Proladone Main Business
Table 128. Proladone Latest Developments
Table 129. Targin Basic Information, Oxycodone Drug Manufacturing Base, Sales Area and Its Competitors
Table 130. Targin Oxycodone Drug Product Portfolios and Specifications
Table 131. Targin Oxycodone Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. Targin Main Business
Table 133. Targin Latest Developments
LIST OF FIGURES
Figure 2. Oxycodone Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oxycodone Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Oxycodone Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Oxycodone Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Pain Management
Figure 10. Product Picture of Anesthesia
Figure 11. Product Picture of Others
Figure 12. Global Oxycodone Drug Sales Market Share by Type in 2023
Figure 13. Global Oxycodone Drug Revenue Market Share by Type (2019-2024)
Figure 14. Oxycodone Drug Consumed in Hospitals & Clinics
Figure 15. Global Oxycodone Drug Market: Hospitals & Clinics (2019-2024) & (K Units)
Figure 16. Oxycodone Drug Consumed in Ambulatory Surgical Centers (ASCs)
Figure 17. Global Oxycodone Drug Market: Ambulatory Surgical Centers (ASCs) (2019-2024) & (K Units)
Figure 18. Global Oxycodone Drug Sales Market Share by Application (2023)
Figure 19. Global Oxycodone Drug Revenue Market Share by Application in 2023
Figure 20. Oxycodone Drug Sales Market by Company in 2023 (K Units)
Figure 21. Global Oxycodone Drug Sales Market Share by Company in 2023
Figure 22. Oxycodone Drug Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Oxycodone Drug Revenue Market Share by Company in 2023
Figure 24. Global Oxycodone Drug Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Oxycodone Drug Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Oxycodone Drug Sales 2019-2024 (K Units)
Figure 27. Americas Oxycodone Drug Revenue 2019-2024 ($ Millions)
Figure 28. APAC Oxycodone Drug Sales 2019-2024 (K Units)
Figure 29. APAC Oxycodone Drug Revenue 2019-2024 ($ Millions)
Figure 30. Europe Oxycodone Drug Sales 2019-2024 (K Units)
Figure 31. Europe Oxycodone Drug Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Oxycodone Drug Sales 2019-2024 (K Units)
Figure 33. Middle East & Africa Oxycodone Drug Revenue 2019-2024 ($ Millions)
Figure 34. Americas Oxycodone Drug Sales Market Share by Country in 2023
Figure 35. Americas Oxycodone Drug Revenue Market Share by Country in 2023
Figure 36. Americas Oxycodone Drug Sales Market Share by Type (2019-2024)
Figure 37. Americas Oxycodone Drug Sales Market Share by Application (2019-2024)
Figure 38. United States Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Oxycodone Drug Sales Market Share by Region in 2023
Figure 43. APAC Oxycodone Drug Revenue Market Share by Regions in 2023
Figure 44. APAC Oxycodone Drug Sales Market Share by Type (2019-2024)
Figure 45. APAC Oxycodone Drug Sales Market Share by Application (2019-2024)
Figure 46. China Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Oxycodone Drug Sales Market Share by Country in 2023
Figure 54. Europe Oxycodone Drug Revenue Market Share by Country in 2023
Figure 55. Europe Oxycodone Drug Sales Market Share by Type (2019-2024)
Figure 56. Europe Oxycodone Drug Sales Market Share by Application (2019-2024)
Figure 57. Germany Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Oxycodone Drug Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Oxycodone Drug Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Oxycodone Drug Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Oxycodone Drug Sales Market Share by Application (2019-2024)
Figure 66. Egypt Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Oxycodone Drug in 2023
Figure 72. Manufacturing Process Analysis of Oxycodone Drug
Figure 73. Industry Chain Structure of Oxycodone Drug
Figure 74. Channels of Distribution
Figure 75. Global Oxycodone Drug Sales Market Forecast by Region (2025-2030)
Figure 76. Global Oxycodone Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Oxycodone Drug Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Oxycodone Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Oxycodone Drug Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Oxycodone Drug Revenue Market Share Forecast by Application (2025-2030)
Figure 2. Oxycodone Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oxycodone Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Oxycodone Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Oxycodone Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Pain Management
Figure 10. Product Picture of Anesthesia
Figure 11. Product Picture of Others
Figure 12. Global Oxycodone Drug Sales Market Share by Type in 2023
Figure 13. Global Oxycodone Drug Revenue Market Share by Type (2019-2024)
Figure 14. Oxycodone Drug Consumed in Hospitals & Clinics
Figure 15. Global Oxycodone Drug Market: Hospitals & Clinics (2019-2024) & (K Units)
Figure 16. Oxycodone Drug Consumed in Ambulatory Surgical Centers (ASCs)
Figure 17. Global Oxycodone Drug Market: Ambulatory Surgical Centers (ASCs) (2019-2024) & (K Units)
Figure 18. Global Oxycodone Drug Sales Market Share by Application (2023)
Figure 19. Global Oxycodone Drug Revenue Market Share by Application in 2023
Figure 20. Oxycodone Drug Sales Market by Company in 2023 (K Units)
Figure 21. Global Oxycodone Drug Sales Market Share by Company in 2023
Figure 22. Oxycodone Drug Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Oxycodone Drug Revenue Market Share by Company in 2023
Figure 24. Global Oxycodone Drug Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Oxycodone Drug Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Oxycodone Drug Sales 2019-2024 (K Units)
Figure 27. Americas Oxycodone Drug Revenue 2019-2024 ($ Millions)
Figure 28. APAC Oxycodone Drug Sales 2019-2024 (K Units)
Figure 29. APAC Oxycodone Drug Revenue 2019-2024 ($ Millions)
Figure 30. Europe Oxycodone Drug Sales 2019-2024 (K Units)
Figure 31. Europe Oxycodone Drug Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Oxycodone Drug Sales 2019-2024 (K Units)
Figure 33. Middle East & Africa Oxycodone Drug Revenue 2019-2024 ($ Millions)
Figure 34. Americas Oxycodone Drug Sales Market Share by Country in 2023
Figure 35. Americas Oxycodone Drug Revenue Market Share by Country in 2023
Figure 36. Americas Oxycodone Drug Sales Market Share by Type (2019-2024)
Figure 37. Americas Oxycodone Drug Sales Market Share by Application (2019-2024)
Figure 38. United States Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Oxycodone Drug Sales Market Share by Region in 2023
Figure 43. APAC Oxycodone Drug Revenue Market Share by Regions in 2023
Figure 44. APAC Oxycodone Drug Sales Market Share by Type (2019-2024)
Figure 45. APAC Oxycodone Drug Sales Market Share by Application (2019-2024)
Figure 46. China Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Oxycodone Drug Sales Market Share by Country in 2023
Figure 54. Europe Oxycodone Drug Revenue Market Share by Country in 2023
Figure 55. Europe Oxycodone Drug Sales Market Share by Type (2019-2024)
Figure 56. Europe Oxycodone Drug Sales Market Share by Application (2019-2024)
Figure 57. Germany Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Oxycodone Drug Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Oxycodone Drug Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Oxycodone Drug Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Oxycodone Drug Sales Market Share by Application (2019-2024)
Figure 66. Egypt Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Oxycodone Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Oxycodone Drug in 2023
Figure 72. Manufacturing Process Analysis of Oxycodone Drug
Figure 73. Industry Chain Structure of Oxycodone Drug
Figure 74. Channels of Distribution
Figure 75. Global Oxycodone Drug Sales Market Forecast by Region (2025-2030)
Figure 76. Global Oxycodone Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Oxycodone Drug Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Oxycodone Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Oxycodone Drug Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Oxycodone Drug Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Defibrillators Electrode Pads Market Growth 2024-2030
US$ 3,660.00
June 2024
94 pages
Global Medical Pendant and Bridge (Medical Supply Unit) Market Growth 2024-2030
US$ 3,660.00
October 2024
143 pages
Global Dilated Cardiomyopathy Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
February 2024
91 pages
Global Handheld Electric Stimulator Market Growth 2023-2029
US$ 3,660.00
March 2023
121 pages
Global Renal Denervation Devices Market Growth 2023-2029
US$ 3,660.00
February 2023
96 pages
